TMS for Parkinson's (NCT07574164)
Reduce tremor using brain stimulation
- Trial ID
- NCT07574164
- Official Title
- Transcranial Magnetic Stimulation for the Treatment of Tremo
- Goal
- Reduce tremor using brain stimulation
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Oxford
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Essential Tremor, Parkinson's Disease (PD)
- Interventions
- TMS
Summary For Families
They're testing whether transcranial magnetic stimulation can reduce tremor severity in people with essential tremor or Parkinson's disease. TMS uses brief magnetic pulses over the scalp to change activity in the brain circuits that generate tremor, aiming to lower tremor amplitude; it is non-invasive and not a drug, so it does not directly alter levodopa or other Parkinson's medications and can be used alongside them. Adults 18 and older with essential tremor or Parkinson's can join, while anyone with contraindications to brain stimulation, for example certain metal implants or a history of seizures, will be excluded. The small study plans to enroll about 20 people and is run by the University of Oxford.
Locations
- Oxford Center for Integrative Neuroimaging, Oxford, Oxfordshire, United Kingdom
Frequently Asked Questions
- What is this trial testing?
- This trial is studying TMS. They're testing whether transcranial magnetic stimulation can reduce tremor severity in people with essential tremor or Parkinson's disease. TMS uses brief magnetic pulses over the scalp to change activity in the brain circuits that generate tremor, aiming to lower tremor amplitude; it is non-invasive and not a drug, so it does not directly alter levodopa or other Parkinson's medications and can be used alongside them. Adults 18 and older with essential tremor or Parkinson's can join, while anyone with contraindications to brain stimulation, for example certain metal implants or a history of seizures, will be excluded. The small study plans to enroll about 20 people and is run by the University of Oxford.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
- How many visits does this trial involve?
- Study 1 involves two visits on separate days, and Study 2 involves three optional visits separated by at least one week; each session is under two hours.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Brain surgery / implanted device (invasive); Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.
- Does this trial reimburse travel costs?
- Participants are reimbursed for travel expenses but do not receive other financial compensation.